Inventor · disambiguated record
Michiel Luc Maria Van Gool
Also filed as: VAN GOOL MICHIEL LUC M · VAN GOOL MICHIEL LUC MARIA
26 granted patents·14 pending applications·22 citations·filing 2007–2022
92Inventor score
Files withJANSSEN PHARMACEUTICA NV30MACDONALD GREGOR JAMES3BARTOLOMÉ-NEBREDA JOSÉ MANUEL2BARTOLOME-NEBREDA JOSE MANUEL1PASTOR FERNÁNDEZ JOAQUIN1
Top patents by PatentIndex Score
40 records- 0185US10005786B2Substituted 6,7-dihydropyrazolo[1,5-a]pyrazines as negative allosteric modulators of MGLUR2 receptorsJANSSEN PHARMACEUTICA NV·Filed 2015·Granted Jun 26, 2018·3 cites·24 claims
- 0279US8716282B2Imidazo[1,2-b]pyridazine derivatives and their use as PDE10 inhibitorsPASTOR-FERNÁNDEZ JOAQUIN·Filed 2011·Granted May 6, 2014·6 cites·18 claims
- 0375US8791120B2Fast-dissociating dopamine 2 receptor antagonistsMACDONALD GREGOR JAMES·Filed 2008·Granted Jul 29, 2014·2 cites·4 claims
- 0470US9828350B25,6-dihydro-2H-[1,4]oxazin-3-yl-amine derivatives useful as inhibitors of beta-secretase (BACE)JANSSEN PHARMACEUTICA NV·Filed 2016·Granted Nov 28, 2017·1 cites·4 claims
- 0570US9550784B2Inhibitors of phosphodiesterase 10 enzymeJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Jan 24, 2017·2 cites·13 claims
- 0669US8859543B2Imidazo[1,2-a]pyrazine derivatives and their use for the prevention or treatment of neurological, psychiatric and metabolic disorders and diseasesBARTOLOMÉ-NEBREDA JOSÉ MANUEL·Filed 2011·Granted Oct 14, 2014·3 cites·10 claims
- 0768US10005785B2Substituted 6,7-dihydropyrazolo[1,5-a] pyrazines as negative allosteric modulators of mGlUR2 receptorsJANSSEN PHARMACEUTICA NV·Filed 2015·Granted Jun 26, 2018·1 cites·29 claims
- 0867US10106542B2Substituted 6,7-dihydropyrazolo[1,5-a]pyrazines as negative allosteric modulators of mGluR2 receptorsJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Oct 23, 2018·1 cites·25 claims
- 0966US10112949B26,7-dihydropyrazolo[1,5-a]pyrazin-4(5H)-one compounds and their use as negative allosteric modulators of mGluR2 receptorsJANSSEN PHARMACEUTICA NV·Filed 2015·Granted Oct 30, 2018·1 cites·24 claims
- 1065US10072014B26,7-dihydropyrazolo[1,5-a]pyrazin-4(5H)-one compounds and their use as negative allosteric modulators of MGLUR2 receptorsJANSSEN PHARMACEUTICA NV·Filed 2015·Granted Sep 11, 2018·1 cites·14 claims
- 1164US10668065B26,7-dihydropyrazolo[1,5-a]pyrazin-4(5H)-one compounds and their use as negative allosteric modulators of mGluR2 receptorsJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Jun 2, 2020·0 cites·27 claims
- 1264US10106524B22,3,4,5-tetrahydropyridin-6-amine and 3,4-dihydro-2H-pyrrol-5-amine compound inhibitors of beta-secretaseJANSSEN PHARMACEUTICA NV·Filed 2015·Granted Oct 23, 2018·1 cites·16 claims
- 1362US10512646B2Substituted 6,7-dihydropyrazolo[1,5-a]pyrazines as negative allosteric modulators of mGluR2 receptorsJANSSEN PHARMACEUTICA NV·Filed 2018·Granted Dec 24, 2019·0 cites·9 claims
- 1460US2024279223A15-oxo-pyrido[2,3-d]pyridazin-6(5h)-yl acetamidesJANSSEN PHARMACEUTICA NV·Filed 2022·Application pending·0 cites
- 1559US2024239757A1Phthalazinone derivates as nlrp3 inflammasome inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2022·Application pending·0 cites
- 1658US2024109905A14-alkoxy-6-oxo-pyridazine derivatives modulating nlrp3JANSSEN PHARMACEUTICA NV·Filed 2022·Application pending·0 cites
- 1758US2024174670A14-amino-6-oxo-pyridazine derivatives modulating nlrp3JANSSEN PHARMACEUTICA NV·Filed 2022·Application pending·0 cites
- 1857US2023391756A1New compoundJANSSEN PHARMACEUTICA NV·Filed 2021·Application pending·0 cites
- 1956US2023183248A1Pyrrolo[1,2-d][1,2,4]triazine-2-yl-acetamides as inhibitors of the nlrp3 inflammasome pathwayJANSSEN PHARMACEUTICA NV·Filed 2021·Application pending·0 cites
- 2056US2024043450A1New compoundJANSSEN PHARMACEUTICA NV·Filed 2021·Application pending·0 cites
- 2156US2023203044A1Pyrazolo[1,5-d][1,2,4]triazine-5(4h)-acetamides as inhibitors of the nlrp3 inflammasomeJANSSEN PHARMACEUTICA NV·Filed 2021·Application pending·0 cites
- 2255US2023183249A1New triazinoindole compoundsJANSSEN PHARMACEUTICA NV·Filed 2021·Application pending·0 cites
- 2355US2023202989A1CompoundsJANSSEN PHARMACEUTICA NV·Filed 2021·Application pending·0 cites
- 2454US9422296B2Fast-dissociating dopamine 2 receptor antagonistsJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Aug 23, 2016·0 cites·5 claims
- 2554US2023203064A1Tricyclic compounds as inhibitors of nlrp3JANSSEN PHARMACEUTICA NV·Filed 2021·Application pending·0 cites
- 2651US11045562B2Radiolabelled mGluR2/3 PET ligandsJANSSEN PHARMACEUTICA NV·Filed 2016·Granted Jun 29, 2021·0 cites·4 claims
- 2750US10584129B2Substituted 6,7-dihydropyrazolo[1,5-a]pyrazines as negative allosteric modulators of mGluR2 receptorsJANSSEN PHARMACEUTICA NV·Filed 2018·Granted Mar 10, 2020·0 cites·25 claims
- 2850US10519162B26,7-dihydropyrazolo[1,5-α]pyrazin-4(5H)-one compounds and their use as negative allosteric modulators of mGluR2 receptorsJANSSEN PHARMACEUTICA NV·Filed 2018·Granted Dec 31, 2019·0 cites·20 claims
- 2950US8933101B2Thia(dia)zoles as fast dissociating dopamine 2 receptor antagonistsMACDONALD GREGOR JAMES·Filed 2008·Granted Jan 13, 2015·0 cites·7 claims
- 3050US8895562B2Piperazin-1-yl-trifluoromethyl-substituted-pyridines as fast dissociating dopamine 2 receptor antagonistsBARTOLOMÉ-NEBREDA JOSÉ MANUEL·Filed 2009·Granted Nov 25, 2014·0 cites·5 claims
- 3149US10967078B2Radiolabelled mGluR2 PET ligandsJANSSEN PHARMACEUTICA NV·Filed 2015·Granted Apr 6, 2021·0 cites·2 claims
- 3249US8466153B2Piperidinylamino-pyridazines and their use as fast dissociating dopamine 2 receptor antagonistsMACDONALD GREGOR JAMES·Filed 2007·Granted Jun 18, 2013·0 cites·7 claims
- 3348US10220032B26,7-dihydropyrazolo[1,5-a]pyrazin-4(5H)-one compounds and their use as negative allosteric modulators of mGluR2 receptorsJANSSEN PHARMACEUTICA NV·Filed 2015·Granted Mar 5, 2019·0 cites·10 claims
- 3447US2010137368A1Pyridine derivatives as fast dissociating dopamine 2 receptor antagonistsJANSSEN PHARMACEUTICA NV·Filed 2008·Application pending·0 cites
- 3546US8530474B2Substituted 6-(1-piperazinyl)-pyridazines as 5-HT6 receptor antagonistsBARTOLOME-NEBREDA JOSE MANUEL·Filed 2009·Granted Sep 10, 2013·0 cites·10 claims
- 3643US11033641B2Radiolabelled mGluR2/3 pet ligandsJANSSEN PHARMACEUTICA NV·Filed 2016·Granted Jun 15, 2021·0 cites·12 claims
- 3742US2012220581A1IMIDAZO[1,2-b]PYRIDAZINE DERIVATIVES AND THEIR USE AS PDE10 INHIBITORSPASTOR-FERNANDEZ JOAQUIN·Filed 2010·Application pending·0 cites
- 3841US2013109683A15,6-dihydro-2h-[1,4]oxazin-3-yl-amine derivatives useful as inhibitors of beta-secretase (bace)TRABANCO-SUAREZ ANDRES AVELINO·Filed 2011·Application pending·0 cites
- 3936US9346811B26,7-dihydro-pyrazolo[1,5-a]pyrazin-4-ylamine derivatives useful as inhibitors of beta-secretase (BACE)TRABANCO-SUÁREZ ANDRÉS AVELINO·Filed 2012·Granted May 24, 2016·0 cites·12 claims
- 4034US10017514B26,7-dihydropyrazolo[1,5-α]pyrazin-4(5H)-one compounds and their use as negative allosteric modulators of mGluR2 receptorsJANSSEN PHARMACEUTICA NV·Filed 2015·Granted Jul 10, 2018·0 cites·19 claims
Join the waitlist — get patent alerts
Get an alert when Michiel Luc Maria Van Gool files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →